3-V Biosciences Garners $30,000,000 Series B Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3a975a5b-0a2c-41e8-89bd-a162767b056f&Preview=1 -
Date
8/6/2009 -
Company Name
3-V Biosciences -
Mailing Address
2225 East Bayshore Road Palo Alto, CA 94303 -
Company Description
3-V Biosciences was founded by The Column Group (TCG) and Kleiner Perkins Caulfield & Byers (KPCB) in March 2007. In April 2007, the original laboratory was opened in Zürich, Switzerland in close proximity to the company’s founders at the ETH (Swiss Federal Institute of Technology) and the University of Zürich. Host pathway screening began in November 2007 and continues today. -
Website
http://www.3vbio.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$30,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The capital will be used for both exploratory research and early clinical development of the company’s lead programs targeting the treatment of respiratory viral infections. -
M&A Terms
-
Venture Investor
New Enterprise Associates -
Venture Investor
The Column Group -
Venture Investor
Kleiner Perkins Caufield & Byers
